
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.300 | 1.420 | 0.120 |
Stocks | 98.660 | 98.660 | 0.000 |
Other | 0.050 | 0.050 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.250 | 18.285 |
Price to Book | 2.498 | 3.093 |
Price to Sales | 1.623 | 2.252 |
Price to Cash Flow | 10.731 | 12.491 |
Dividend Yield | 2.552 | 2.009 |
5 Years Earnings Growth | 11.523 | 10.608 |
Name | Net % | Category Average |
---|---|---|
Technology | 25.150 | 24.068 |
Industrials | 15.440 | 11.430 |
Healthcare | 14.590 | 13.047 |
Financial Services | 13.600 | 16.341 |
Consumer Cyclical | 8.790 | 10.767 |
Communication Services | 6.270 | 7.999 |
Basic Materials | 6.140 | 3.925 |
Consumer Defensive | 4.950 | 7.558 |
Utilities | 2.890 | 2.535 |
Real Estate | 1.190 | 2.713 |
Energy | 1.010 | 3.477 |
Number of long holdings: 945
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 5.15 | 239.07 | +1.59% | |
Microsoft | US5949181045 | 3.76 | 393.31 | -0.90% | |
Nordea 2 - Global Enhanced Equity Y DKK | LU0994677200 | 2.62 | - | - | |
Nordea 2 - EM Enhanced Equity Y DKK | LU0994674017 | 1.88 | - | - | |
Novo Nordisk B | DK0062498333 | 1.83 | 564.7 | -5.51% | |
NVIDIA | US67066G1040 | 1.75 | 112.69 | +1.92% | |
DSV | DK0060079531 | 1.13 | 1,427.5 | +0.21% | |
Eli Lilly | US5324571083 | 1.12 | 869.58 | -4.73% | |
Danske Bank | DK0010274414 | 1.12 | 236.3 | -1.83% | |
Taiwan Semicon | TW0002330008 | 0.99 | 1,005.00 | 0.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nordea Invest Portefolje Aktier Str | 3.96B | 1.29 | 8.60 | 8.60 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review